Lifestyle Factors and Cancer Survivorship: Observational Findings of Weight, Physical Activity, and Diet on Survival
|
|
- Eugene Harrell
- 6 years ago
- Views:
Transcription
1 Lifestyle Factors and Cancer Survivorship: Observational Findings of Weight, Physical Activity, and Diet on Survival Melinda L. Irwin, PhD, MPH Associate Professor of Epidemiology Yale School of Medicine Yale School of Public Health
2 AICR s 2009 Annual Research Conference on Food, Nutrition, Physical Activity and Cancer November 5-6, 2009 Capital Hilton, Washington, DC No Relevant Financial Relationships No Conflict of Interest
3 Lifestyle Habits and Breast Cancer Survival Despite advances in adjuvant treatment, over 40,000 women still die of breast cancer each year. Current breast cancer therapies do not address the association of obesity and sedentary lifestyle effects on prognosis. Obesity and physical inactivity are common before and after a breast cancer diagnosis.
4 Mortality from Cancer According to BMI for U.S. Women in the Cancer Prevention Study II Calle, E. et al. N Engl J Med 2003;348:
5 Mortality from Cancer According to BMI for U.S. Men in the Cancer Prevention Study II Calle, E. et al. N Engl J Med 2003;348:
6 Meta-analysis Evaluating Measures of Adiposity at Diagnosis and Prognosis Recurrence at 5 yrs Death at 10 yrs HR [95% CI] HR [95% CI] Body Weight 1.78[ ] 1.36[ ] BMI 1.91[ ] 1.60[ ] Goodwin, P.. In: Psychosomatic Obstetrics and Gynecology, Bitzer J. and Stauber M. (Eds); Monduzzi Editore, International Proceedings Division, Bologna (Italy), p , 1995.
7 Weight and Survival in Early-Stage Breast Cancer Estimated Relative Risk of Adverse Event Distant Recurrence, p= Death, p= BMI (kg/m 2 ) Goodwin et al, JCO 2002
8 Post-Diagnosis Weight Gain and Breast Cancer Death in Women with BMI < 25 at diagnosis 2 P trend < HR Breast Cancer Death Maintain Gain < 2.0 kg/m2 Gain > 2.0 kg/m2 Kroenke C JCO 2005
9 In Population Studies, Overweight/Obesity Affects Breast Cancer Prognosis in: Premenopausal patients Postmenopausal patients Patients diagnosed with any disease stage Patients treated with any combination of surgery, radiation, systemic chemotherapy Cheblowski, Aiello, McTiernan JCO 2002;20(4):
10 4 Changes in Exercise Frequency across the Colon Cancer Experience (N = 130) 3 Sessions Per week 2 1 Moderate Strenuous 0 Prediagnosis Active Treatment Post Treatment Courneya K and Friedenreich C. J Altern Complem Med 1997
11 Exercise Patterns across the Colon Cancer Experience (N = 130) % Maintainers Temporary Relapsers Permanent Relapsers Nonexercisers Adopters Courneya K and Friedenreich C. J Altern Complem Med 1997
12 Physical Activity Before and After Diagnosis in Breast Cancer Survivors The HEAL Study P<.05 P<.05 P<.05 Hours/wee Before Diagnosis After Diagnosis In situ Stage I Stage II-IIIa Stage Irwin M. et al. Cancer 2003;97:
13 Physical Activity across the Breast Cancer Experience by BMI (HEAL Study, N = 547) 4 3 Hrs/week Year Before Diagnosis Within 1st Year Post- Diagnosis Within 3rd Year Post- Diagnosis Irwin ML et al MSSE 2004 BMI < 25 BMI: BMI > 30
14 Weight Change from Baseline to 2 yrs by change in PA (N = 544) kg kg * < 90 min/wk min/wk 150+ min/wk Irwin ML et al. JCO, 2005
15 Benefits of Increasing Post-Diagnosis PA Need to encourage cancer survivors to maintain (if active prior to diagnosis) or increase PA after diagnosis. PA is associated with numerous benefits Decreasing adverse side effects of surgery and treatment Improving quality of life and fatigue Improving fitness, functional capacity, and body composition Decreasing serum hormones and growth factors Improving cancer-specific survival and all cause survival
16 Physical Activity and Increased Survival in Breast Cancer Survivors More than four observational studies have examined the relationship between post-diagnosis physical activity and mortality after breast cancer diagnosis % reduced risk with 2-3 hr/wk of moderate-intensity exercise Associations stronger in women with higher disease stage Holmes M et al JAMA 2005; Holick C et al. CEBP 2008; Pierce J et al JCO 2007; Irwin ML et al JCO, 2008.
17 Nurses Health Study: Physical activity after breast cancer diagnosis HR P =.05 P=.004 P =.003 Recurrence BRCA Death Total Death MET-hr/wk MET-Hrs/week < Holmes *p=0.05, M et al JAMA # p<
18 Multivariable-Adjusted Relative Risk of Breast Cancer Death According to 2 Physical Activity Categories After Breast Cancer Diagnosis* Holmes, M. D. et al. JAMA 2005;293:
19 The HEAL Study: Physical Activity after Diagnosis Hazard Ratio for Death P =.46 BC Death P =.04 Total Death MET-hr/wk 0 > Irwin ML et al JCO, 2008.
20 Women s Health Initiative (WHI) WHI enrolled healthy postmenopausal women and collected physical activity information at least every 3 years. ~5430 women developed breast cancer while enrolled in WHI. Pre- and Post-diagnosis PA and other lifestyle and prognostic information were collected prospectively. Irwin, Chlebowski, McTiernan et al.
21 Post-diagnosis Physical Activity and Colorectal Cancer Survival: NHS Findings Meyerhardt, J. A. et al. J Clin Oncol; 24:
22 NHS and Change in Physical Activity Meyerhardt, J. A. et al. J Clin Oncol; 24:
23 The Women s Interventional Nutrition Study (WINS) Randomized 2400 women with early-stage breast cancer to low-fat diet intervention or control group Intervention involved oneon-one meetings with dietician, cooking classes WINS diet: reduce fat to 15% of total calories Chlebowski et al. JNCI, 2006.
24 Results by hormonal subtype ER Negative ER Positive Chlebowski, JNCI 2006
25 The Women s Healthy Eating and Living Study (WHEL) Included 3088 women with earlystage breast cancer Randomized to phone-based diet intervention or control WHEL Diet: High fruits and vegetables Low fat High fiber Pierce, Lancet 2007
26 Impact of Dietary Intervention on DFS Pierce et al., Lancet 2007.
27 Survival after WHEL Study enrollment by four diet and physical activity categories Pierce, J. P. et al. J Clin Oncol; 25: Copyright American Society of Clinical Oncology
28 Insulin and breast cancer prognosis N Hormone Results Goodwin 512 Insulin 2-fold risk of recurrence and 3-fold risk of death in highest vs. lowest quartile Irwin 608 C-peptide 3-fold risk of breast cancer death in top tertile vs. bottom tertile 3.5-fold risk of breast cancer death for women with type 2 diabetes vs. bottom tertile (low c-peptide and no diabetes) Goodwin et al. JCO 2001;20:42-51; Irwin ML, et al. Under review
29 Insulin and Breast Cancer Prognosis Hazard Rat p = p = Distant Recurrence Death > 51.9 Insulin Quartiles (pmol/l) Goodwin et al. JCO 2001;20:42-51
30 C-Peptide and Breast Cancer Death Hazard Ratio p = < > 2.5 T2D C-Peptide Tertiles (ng/ml) Breast Cancer Death Irwin ML, et al. Under Review
31 Sex Steroids Modification of sex steroid levels has long been a mainstay of cancer therapy Early treatment for breast cancer included removal of ovaries, adrenals, and other endocrine organs More recently, aromatase inhibitors, which lower estradiol levels to below detectable levels of most assays, have been shown to significantly improve prognosis and lower risk of second breast cancers
32 Estrogen Levels by BMI in 505 Postmenopausal Breast Cancer Patients pg/m P trend = Estrone Estradiol 5 P trend = < > 30 kg/m 2 McTiernan et al. J. Clin. Oncol. 2003;21:
33 Testosterone Levels by BMI in 505 Postmenopausal Breast Cancer Patient pg/m P trend = < > 30 Testosterone kg/m 2 McTiernan et al. J. Clin. Oncol. 2003;21:
34 Risk of Breast Cancer Death by Adiponectin (HEAL, 566 Stage I-IIIa patients, followed up mean 6 years) P=0.08 Hazard Rat Tertile 1 Tertile 2 Tertile 3 Adiponectin Duggan C, et al. To be submitted
35 2.5 2 Risk of Total Death by CRP (HEAL, 734 Stage 0-IIIa patients, followed up mean 6 years) P for trend=0.01 Hazard Rat <1.2 mg/l mg/l > 3.8 mg/l CRP tertiles Pierce, et al. JCO, In Press
36 Interventions to Increase Physical Activity levels in Cancer Survivors Growing number of exercise interventions conducted pre-surgery, during treatment, and post-treatment treatment Numerous benefits associated with exercise.
37 Future Research Directions Need more studies of lifestyle and survival in other cancers More exercise and weight loss trials with novel endpoints Common side effects of treatment Inflammation Cell proliferation Disease-free survival
38 Conclusions Increasing PA after diagnosis is associated with a decreased risk of breast cancer mortality and all cause mortality Especially among women who are inactive prior to diagnosis! More research is needed on how to maintain weight and increase physical activity after a cancer diagnosis.
39 HEAL Study Acknowledgements Rachel Ballard-Barbash Barbash,, NCI Anne McTiernan,, FHCRC Leslie Bernstein, COH Rick Baumgarter,, Louisville WHI Study Rowan Chlebowski,, UCLA Anne McTiernan,, FHCRC
Breast Cancer: Weight and Exercise. Anne McTiernan, MD, PhD. Fred Hutchinson Cancer Research Center Seattle, WA
Breast Cancer: Weight and Exercise Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA Associations of Obesity with Overall & Breast Cancer Specific Survival Survival Obese vs. Non-obese
More informationBreast Cancer: Weight and Exercise. Anne McTiernan, MD, PhD. Fred Hutchinson Cancer Research Center Seattle, WA
Breast Cancer: Weight and Exercise Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA Associations of Obesity with Overall & Breast Cancer Specific Survival Survival Obese vs. Non-obese
More informationLifestyle Risk Factors and Cancer Prevention
February 3-5, 2016 Lansdowne Resort, Leesburg, VA Lifestyle Risk Factors and Cancer Prevention Melinda L. Irwin, PhD, MPH Professor of Epidemiology, Yale School of Public Health, Associate Director (Population
More informationPhysical Activity & Cancer What We Know, What We Don t Know. Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA
Physical Activity & Cancer What We Know, What We Don t Know Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA What We Know Extensive epidemiologic research on relationship between
More informationBreast Cancer Survivorship
Breast Cancer Survivorship Melissa Accordino, MD Assistant Professor of Medicine Herbert Irving Comprehensive Cancer Center Columbia University Medical Center Who are the Cancer Survivors? More than 1
More informationBreast Cancer Survivorship: Physical Activity
WORKING EVERYDAY TO PROVIDE THE HIGHEST QUALITY OF LIFE FOR PEOPLE WITH CANCER Breast Cancer Survivorship: What is the Role of Diet and Physical Activity WENDY DEMARK-WAHNEFRIED, PHD, RD PROFESSOR AND
More informationLow-Fat Dietary Pattern Intervention Trials for the Prevention of Breast and Other Cancers
Low-Fat Dietary Pattern Intervention Trials for the Prevention of Breast and Other Cancers Ross Prentice Fred Hutchinson Cancer Research Center and University of Washington AICR, November 5, 2009 Outline
More informationPhysical activity, Obesity, Diet and Colorectal Cancer Prognosis. Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA
Physical activity, Obesity, Diet and Colorectal Cancer Prognosis Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA Colorectal Cancer Incidence ~148,000 cases in US annually and ~50,000
More informationInfluence of Weight Management and Exercise on Other Outcomes
Influence of Weight Management and Exercise on Other Outcomes Melinda L. Irwin, PhD, MPH Professor of Epidemiology, Yale School of Public Health Associate Director for Population Sciences, Yale Cancer
More informationJournal of Clinical Oncology
Journal of Clinical Oncology Copy of e-mail Notification zlj7630 Your article (# 59822) from Journal of Clinical Oncology is available for download ===== Journal of Clinical Oncology Article no. 59822
More informationPhysical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review
JNCI Journal of the National Cancer Institute Advance Access published May 8, 2012 DOI: 10.1093/jnci/djs207 Published by Oxford University Press 2012. REVIEW Physical Activity, Biomarkers, and Disease
More informationSoyfood Consumption and Breast Cancer Survival. Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A.
Soyfood Consumption and Breast Cancer Survival Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A. Objectives Brief summary of the health benefits of soyfood consumption
More informationLeveraging Prospective Cohort Studies to Advance Colorectal Cancer Prevention, Treatment and Biology
Leveraging Prospective Cohort Studies to Advance Colorectal Cancer Prevention, Treatment and Biology Charles S. Fuchs, MD, MPH Director, Yale Cancer Center Physician-in-Chief, Smilow Cancer Hospital New
More informationSoyfood Consumption and Breast Cancer Survival. Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A.
Soyfood Consumption and Breast Cancer Survival Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A. Objectives Brief summary of the health benefits of soyfood consumption
More informationNew Insights into Breast Cancer Risk Reduction
New Insights into Breast Cancer Risk Reduction November 10, 2013 Rowan T. Chlebowski Professor of Medicine David Geffen School of Medicine at UCLA Chief, Division of Medical Oncology and Hematology Harbor-UCLA
More informationObesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities Sao Jiralerspong and Pamela J. Goodwin
VOLUME 34 NUMBER 35 DECEMBER 10, 2016 JOURNAL OF CLINICAL ONCOLOGY R E V I E W A R T I C L E Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities Sao Jiralerspong and Pamela J.
More informationObservational Studies vs. Randomized Controlled Trials
Observational Studies vs. Randomized Controlled Trials Edward Giovannucci, MD, ScD Harvard School of Public Health Harvard Medical School Boston MA 02115 (1)The relevance of observational data as compared
More informationExercise as Medicine for Cancer Management. Robert U. Newton, PhD
Exercise as Medicine for Cancer Management Robert U. Newton, PhD What is Anabolic Exercise? Repetitive movements performed against resistance Resistance limits number completed e.g. 10 reps per set (10RM)
More informationAnthropometry: What Can We Measure & What Does It Mean?
Anthropometry: What Can We Measure & What Does It Mean? Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, Washington, U.S.A. I have no conflicts to disclose. Anthropometry in Human
More information4/13/2010. Silverman, Buchanan Breast, 2003
Tailoring Breast Cancer Treatment: Has Personalized Medicine Arrived? Judith Luce, M.D. San Francisco General Hospital Avon Comprehensive Breast Care Center Outline First, treatment of DCIS Sorting risk
More informationOptimal Nutritional Goals for the Cancer Survivor
W O R K I N G E V E R Y D A Y T O P R O V I D E T H E H I G H E S T Q U A L I T Y O F L I F E F O R P E O P L E W I T H C A N C E R Optimal Nutritional Goals for the Cancer Survivor W E N D Y D E M AR
More informationEating and Exercising toward Better Health in Cancer Survivors
W O R K I N G E V E R Y D A Y T O P R O V I D E T H E H I G H E S T Q U A L I T Y O F L I F E F O R P E O P L E W I T H C A N C E R Eating and Exercising toward Better Health in Cancer Survivors W E N
More informationUpdate from the 29th Annual San Antonio Breast Cancer Symposium
Update from the 29th Annual San Antonio Breast Cancer Symposium The San Antonio Breast Cancer Symposium is one of the most important breast cancer conferences. Approximately 8,000 physicians, oncologists,
More informationThis paper is available online at
Thomson CA, Van Horn L, Caan BJ, Aragaki AK, Chlebowski RT, Manson JE, Rohan TE, Tinker LF, Kuller LH, Hou L, Lane DS, Johnson KC, Vitolins M, Prentice R. This paper is available online at http://cebp.aacrjournals.org/cgi/content/abstract/1055-9965.epi-14-0922
More informationSurvivorship: Lifestyle Modifications of Diet and Exercise
Survivorship: Lifestyle Modifications of Diet and Exercise Alice S. Ryan, PhD Professor Division of Gerontology and Geriatric Medicine University of Maryland School of Medicine VA Senior Research Career
More informationPamela J. Goodwin, M.D., M.Sc., F.R.C.P.C.
Overview of the Evidence Relating Cancer Outcomes to Obesity and Body Weight Pamela J. Goodwin, M.D., M.Sc., F.R.C.P.C. Professor of Medicine University of Toronto Obesity Trends* Among U.S. Adults BRFSS,
More informationPhysical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study
DOI 10.1007/s10552-010-9714-3 ORIGINAL PAPER Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study Lisa A. Cadmus Bertram
More informationChapter 2 The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence
Chapter 2 The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence 2.1 BMI and Breast Cancer Risk BMI is routinely used to qualify an individual s adiposity, yet it is simply a measure
More informationObesity and Breast Cancer Risk in Hispanics: Findings from the Breast Cancer Health Disparities Study
Obesity and Breast Cancer Risk in Hispanics: Findings from the Breast Cancer Health Disparities Study Esther M. John, PhD, MSPH Senior Research Scientist Cancer Prevention Institute of California AICR
More informationSurvivorship and Breast Cancer in Older Patients
Survivorship and Breast Cancer in Older Patients Michelle Melisko MD Clinical Professor of Medicine UCSF Helen Diller Family Comprehensive Cancer Center Disclosures Research support: Nektar, Novartis,
More informationHost Factors that Increase Breast Cancer Risk
Host Factors that Increase Breast Cancer Risk 30 th Annual Miami Breast Cancer Conference March 7-10, 2013 Debu Tripathy, MD Professor of Medicine University of Southern California Norris Comprehensive
More informationMedical risk reducing strategies for breast cancer
Medical risk reducing strategies for breast cancer PROF. DR. H. DEPYPERE Menopause Clinic, University Hospital, Ghent, Belgium Life expectancy in Belgium 46,6 y in 1880 and 83,8 y in 2014 2 Women Men Aantal
More informationHEALTH CARE DISPARITIES. Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center
HEALTH CARE DISPARITIES Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center Goals Understand the epidemiology of breast cancer Understand the broad management of breast cancer
More informationExtended Hormonal Therapy
Extended Hormonal Therapy Dr. Caroline Lohrisch, Medical Oncologist, BC Cancer Agency Vancouver Centre November 1, 2014 www.fpon.ca Optimal Endocrine Therapy for Women with Hormone Receptor Positive Early
More informationNo effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial
University of North Florida UNF Digital Commons Nutrition and Dietetics Faculty Publications Department of Nutrition and Dietetics 11-2010 No effect of exercise on insulin-like growth factor (IGF)-1, insulin
More informationObesity and Cancer Survivorship. Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona
Obesity and Cancer Survivorship Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona Objectives Describe the relationship between obesity, weight gain
More informationBeyond Standard Therapy for Colorectal Cancer: Role of Energy Balance in Treatment of Survivors
Beyond Standard Therapy for Colorectal Cancer: Role of Energy Balance in Treatment of Survivors Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA 1 Disclosure Ad Board: Genentech Honorarium:
More informationCancer Survivors: - Asian Perspective
Cancer Survivors: What we Know, What we Need to Know - Asian Perspective Prof. Josette Sin-yee Chor School of Public Health and Primary Care The Chinese University of Hong Kong Asia Varying incidence of
More informationWhat is new in HR+ Breast Cancer? Olivia Pagani Breast Unit and Institute of oncology of Southern Switzerland
What is new in HR+ Breast Cancer? Olivia Pagani Breast Unit and Institute of oncology of Southern Switzerland Outline Early breast cancer Advanced breast cancer Open questions Outline Early breast cancer
More informationSymposium 6 Part ll BAPEN M d e i di l ca /N l/n t u irti ition S i oc t e y Nutritional Science i n in C ancer Cancer
Symposium 6 Part ll BAPEN Medical/Nutrition iti Society Nutritional Science in Cancer Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective Professor Martin Wiseman FRCP
More informationSOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer
SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer Charles Moertel Lecture May 12, 2017 Gini Fleming Charles Moertel Founder of NCCTG Dedication to high quality clinical
More informationEvidence for the Role of Obesity in Breast Cancer Progression
Evidence for the Role of Obesity in Breast Cancer Progression Pamela J. Goodwin, M.D., M.Sc., F.R.C.P.C. Professor of Medicine Mount Sinai and Princess Margaret Hospitals University of Toronto BMI and
More informationThe Role of Observational Studies. Edward Giovannucci, MD, ScD Departments of Nutrition and Epidemiology
The Role of Observational Studies Edward Giovannucci, MD, ScD Departments of Nutrition and Epidemiology Disclosure Information As required, I would like to report that I have no financial relationships
More informationIssues in Cancer Survivorship. Larissa A. Korde, MD, MPH June 26, 2010
Issues in Cancer Survivorship Larissa A. Korde, MD, MPH June 26, 2010 Estimated US Cancer Cases in Women: 2006-2008 CA Cancer J Clin 2006; 56:106-130; CA Cancer J Clin 2008;58:71 96. Relative Survival*
More informationSeigo Nakamura,M.D.,Ph.D.
Seigo Nakamura,M.D.,Ph.D. Professor of Surgery Director of Breast Center Showa University Hospital Chairman of the board of directors Japan Breast Cancer Society Inhibition of Estrogen-Dependent Growth
More informationEarly Stage Disease. Hope S. Rugo, MD Professor of Medicine Director Breast Oncology and Clinical Trials Education UCSF Comprehensive Cancer Center
SABCS 2014: Early Stage Disease Hope S. Rugo, MD Professor of Medicine Director Breast Oncology and Clinical Trials Education UCSF Comprehensive Cancer Center Topics for Discussion Chemotherapy plus 10
More informationIncreased Risk of Breast Cancer: Screening and Prevention. Elizabeth Pritchard, MD 4/5/2017
Increased Risk of Breast Cancer: Screening and Prevention Elizabeth Pritchard, MD 4/5/2017 No disclosures Defining Risk Risk Factors Modifiable Lifestyle obesity physical activity alcohol consumption breast
More information8/8/2011. PONDERing the Need to TAILOR Adjuvant Chemotherapy in ER+ Node Positive Breast Cancer. Overview
Overview PONDERing the Need to TAILOR Adjuvant in ER+ Node Positive Breast Cancer Jennifer K. Litton, M.D. Assistant Professor The University of Texas M. D. Anderson Cancer Center Using multigene assay
More informationSurgical treatment of BRCA mutated patients. Viviana Galimberti MD European Institute of Oncology Milan, Italy
Surgical treatment of BRCA mutated patients Viviana Galimberti MD European Institute of Oncology Milan, Italy No pharmaceutical company funding was used I declare I have no conflicts of interest as regards
More informationNutrition and gastrointestinal cancer: An update of the epidemiological evidence
Nutrition and gastrointestinal cancer: An update of the epidemiological evidence Krasimira Aleksandrova, PhD MPH Nutrition, Immunity and Metabolsim Start-up Lab Department of Epidemiology German Institute
More information부인암생존자의건강관리 - 암생존자의식이와운동요법
제 32 차대한부인종양학회춘계학술대회 부인암생존자의건강관리 - 암생존자의식이와운동요법 Mi-Kyung Kim, MD, PhD Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cheil General Hospital & Women s Healthcare Center Dankook
More informationWhat is survivorship? Late effects of treatment. Concerns of survivorship
Choices to enhance vitality!!!and survival!!!!!!!!! (and how to make it work in the real world)! What is survivorship? Multiple definitions! Anyone living with cancer at any stage since diagnosis! Anyone
More informationEmerging Approaches for (Neo)Adjuvant Therapy for ER+ Breast Cancer
Emerging Approaches for (Neo)Adjuvant Therapy for E+ Breast Cancer Cynthia X. Ma, M.D., Ph.D. Associate Professor of Medicine Washington University in St. Louis Outline Current status of adjuvant endocrine
More informationBSO, HRT, and ERT. No relevant financial disclosures
BSO, HRT, and ERT Jubilee Brown, MD Professor & Associate Director, Gynecologic Oncology Levine Cancer Institute at the Carolinas HealthCare System Charlotte, North Carolina No relevant financial disclosures
More informationUse of Ovarian Suppression and Ablation in Breast Cancer Treatment
Use of Ovarian Suppression and Ablation in Breast Cancer Treatment Dr Marina Parton Consultant Medical Oncologist Royal Marsden and Kingston Hospitals Overview Breast cancer phenotypes Use of ovarian manipulation
More informationObjectives. Survivors. Survivorship in Cancer 7/20/2018. Over 15 million survivors in the U.S. Over 32 million worldwide. Oncology Survivorship Care
Survivorship in Cancer Oncology Survivorship Care Kathleen Martin, FNP-BC, AOCNP Objectives Define population of survivors of cancer Define the need for survivorship care Explain the purpose of survivorship
More informationBREAST CANCER AND BONE HEALTH
BREAST CANCER AND BONE HEALTH Rowena Ridout, MD, FRCPC Toronto Western Hospital Osteoporosis Program University Health Network / Mount Sinai Hospital rowena.ridout@uhn.ca None to declare Conflicts of Interest
More informationAnalysing research on cancer prevention and survival. Diet, nutrition, physical activity and breast cancer survivors. In partnership with
Analysing research on cancer prevention and survival Diet, nutrition, physical activity and breast cancer survivors 2014 In partnership with Contents About World Cancer Research Fund International 1 Our
More informationComparative effectiveness of strategies to prevent weight gain among women with and at risk for breast cancer: a systematic review
Chaudhry et al. SpringerPlus 2013, 2:277 a SpringerOpen Journal SHORT REPORT Open Access Comparative effectiveness of strategies to prevent weight gain among women with and at risk for breast cancer: a
More informationObesity and Breast Cancer in a Multiethnic Population. Gertraud Maskarinec, MD, PhD University of Hawaii Cancer Center, Honolulu, HI
Obesity and Breast Cancer in a Multiethnic Population Gertraud Maskarinec, MD, PhD University of Hawaii Cancer Center, Honolulu, HI Background Breast cancer incidence remains lower in many Asian than Western
More informationAdjuvant Endocrine Therapy: How Long is Long Enough?
Adjuvant Endocrine Therapy: How Long is Long Enough? Harold J. Burstein, MD, PhD Dana-Farber Cancer Institute Harvard Medical School Boston, Massachusetts hburstein@partners.org I have no conflicts to
More informationThe Breast Cancer Weight Loss (BWEL) Trial
Plenary Session: Integrative Innovations in Digital Health Technologies with Cancer Patients and Survivors The Breast Cancer Weight Loss (BWEL) Trial Jennifer Ligibel, MD Dana-Farber Cancer Institute SIO
More informationBody Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)
JNCI J Natl Cancer Inst (2015) 107(9): djv179 doi:10.1093/jnci/djv179 First published online June 25, 2015 Article Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationAlcohol & Cancer: from prevention to the patient
Alcohol & Cancer: from prevention to the patient -from consistency to inconsistencies- Ellen Kampman Wageningen University Academic Medical Centre St Radboud Nijmegen 23 september 2010 Alcohol and the
More informationBreast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime
Breast Cancer and Bone Loss One in seven women will develop breast cancer during a lifetime Causes of Bone Loss in Breast Cancer Patients Aromatase inhibitors Bil Oophorectomy Hypogonadism Steroids Chemotherapy
More informationIdentifying and Meeting the Medical and Psychological Needs of Cancer Survivors Ann H. Partridge, MD, MPH
Identifying and Meeting the Medical and Psychological Needs of Cancer Survivors Ann H. Partridge, MD, MPH 2017 Master Class Course Presenter Disclosure Information The following relationships exist related
More information38 years old, premenopausal, had L+snbx. Pathology: IDC Gr.II T-1.9cm N+2/4sn ER+100%st, PR+60%st, Her2-neg, KI %
38 years old, premenopausal, had L+snbx Pathology: IDC Gr.II T-1.9cm N+2/4sn ER+100%st, PR+60%st, Her2-neg, KI67 5-10% Question: What will you do now? 1. Give adjuvant chemotherapy 2. Send for Oncotype
More information2/16/2017. Welcome to the COPE Webinar Series for Health Professionals! MacDonald Center for Obesity Prevention and Education (COPE) Goals
Welcome to the COPE Webinar Series for Health Professionals! February 22, 2017 12 Noon-1 PM EST Diet Modification as a Novel Therapeutic for Cancer Treatment: When Less is More Moderator: Lisa Diewald,
More information2/16/2017. CE Credits. CE Credits. Diet Modification as a Novel Therapeutic in Cancer Treatment: When Less is More
Welcome to the COPE Webinar Series for Health Professionals! MacDonald Center for Obesity Prevention and Education (COPE) Goals February 22, 2017 12 Noon-1 PM EST Diet Modification as a Novel Therapeutic
More informationBreast Cancer The PRECAMA Study. Dr. Isabelle Romieu Head, Section of Nutrition and Metabolism
Breast Cancer The PRECAMA Study Dr. Isabelle Romieu Head, Section of Nutrition and Metabolism Estimated incidence of breast cancer (2008) Age- standardised rates per 100,000 GLOBOCAN 2008 (globocan.iarc.fr)
More informationCurrent Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF
Current Strategies in the Detection of Breast Cancer Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF Outline ν Screening Film Mammography ν Film ν Digital ν Screening
More informationDiet and Cancer: Prevention, Treatment and Survival
Diet and Cancer: Prevention, Treatment and Survival Tracy Crane, MS, RD Research Specialist, Sr. The University of Arizona Cancer Center and College of Public Health Educational Series Disclosure All Faculty,
More informationWilliam J. Gradishar MD
Northwestern University Feinberg School of Medicine Adjuvant Endocrine Therapy For Postmenopausal Women SOBO 2013 William J. Gradishar MD Betsy Bramsen Professor of Breast Oncology Director, Maggie Daley
More informationThe Latest Research: Hormonal Therapies
The Latest Research: Hormonal Therapies Sameer Gupta, M.D., M.P.H 9/29/2018 Attending Physician, Hematology/Oncology Bryn Mawr Hospital Clinical Assistant Professor, Jefferson Medical College Disclosures
More information6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention
6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology
More informationHormone therapy in Breast Cancer patients with comorbidities
Hormone therapy in Breast Cancer patients with comorbidities Diana Crivellari Centro di Riferimento Oncologico Aviano- ITALY Madrid November 9th, 2007 Main issues Comorbidities in elderly women Hormonal
More informationObesity and Cancer Survivorship: Where are we in Providing Care? Cynthia Thomson, PhD, RD Mary Koithan, PhD, RN, CNS-BC
Obesity and Cancer Survivorship: Where are we in Providing Care? Cynthia Thomson, PhD, RD Mary Koithan, PhD, RN, CNS-BC Objectives This webinar will help you: Describe the relationship between obesity,
More informationObesity and Breast Cancer Risk
Program on Breast Cancer Environmental Risk Factors Fact Sheet #56 August 2007 TOPICS Measurement of obesity BMI and breast cancer risk Weight gain and loss and breast cancer risk Body fat distribution
More informationORMONOTERAPIA ADIUVANTE: QUALE LA DURATA OTTIMALE? MARIANTONIETTA COLOZZA
ORMONOTERAPIA ADIUVANTE: QUALE LA DURATA OTTIMALE? MARIANTONIETTA COLOZZA THE NATURAL HISTORY OF HORMONE RECEPTOR- POSITIVE BREAST CANCER IS VERY LONG Recurrence hazard rate 0.3 0.2 0.1 0 ER+ (n=2,257)
More informationManejo do câncer de mama RH+ na adjuvância: o que há de novo?
II Simpósio Internacional de Câncer de Mama para o Oncologista Clínico Manejo do câncer de mama RH+ na adjuvância: o que há de novo? INGRID A. MAYER, MD, MSCI Assistant Professor of Medicine Director,
More informationBreast SSG Education Event Anglia Cancer Network Sally Donaghey Macmillan AHP Lead
Breast SSG Education Event Anglia Cancer Network 10.2.2012 Sally Donaghey Macmillan AHP Lead sally.donaghey@suffolk.pct.nhs.uk IPx People affected by cancer need information that is timely, relevant, and
More informationDiet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford
Diet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford Diet and cancer Diet and cancer Nutrition research Lack of funding RCTs Low quality Small sample sizes
More informationSAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:
Patient: Age: 40 Sex: F MRN: SAMPLE PATIENT Order Number: Completed: Received: Collected: SAMPLE REPORT Progesterone ng/ml 0.34 0.95 21.00 DHEA-S mcg/dl Testosterone ng/ml 48 35 0.10 0.54 0.80 430 Sex
More informationRacial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective 1 3
REVIEW Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer and Survival: A Global Perspective 1 3 Elisa V Bandera, 4,5 * Gertraud Maskarinec, 6 Isabelle Romieu, 7 and Esther M John
More informationDiabetes Mellitus and Breast Cancer
Masur K, Thévenod F, Zänker KS (eds): Diabetes and Cancer. Epidemiological Evidence and Molecular Links. Front Diabetes. Basel, Karger, 2008, vol 19, pp 97 113 Diabetes Mellitus and Breast Cancer Ido Wolf
More informationConnecting Links for Reducing Risks: Understanding the impact of obesity on cancer development. Kristi Acker, DNP, FNP-BC, AOCNP, ACHPN
Connecting Links for Reducing Risks: Understanding the impact of obesity on cancer development Kristi Acker, DNP, FNP-BC, AOCNP, ACHPN Objectives 1) Identify factors that contribute to the financial burden
More informationThe Center for Cancer Prevention and Treatment Public Reporting of Outcomes
The Center for Cancer Prevention and Treatment 2017 Public Reporting of Outcomes Cancer Screening Program - CoC Standard 4.2 Oral Cancer Screening Event Identified Community Need According to the 2014
More informationNutrition and Cancer Prevention. Elisa V. Bandera, MD, PhD
Nutrition and Cancer Prevention Elisa V. Bandera, MD, PhD The Causes of Cancer in the US. Sedentary lifestyle 5% Other 12% Family history 5 % Occupation 5% Tobacco 30% Reproductive factors 3% Pollution
More informationIntegrative Medicine at SCCA: A New Program for Survivors
Integrative Medicine at SCCA: A New Program for Survivors Heather Greenlee, ND, PhD Medical Director, Integrative Medicine Program Associate Member, Fred Hutch Associate Professor, UW School of Medicine
More informationSurvivors of breast and other cancers
Survivors of breast and other cancers 2018 Contents World Cancer Research Fund Network 3 Introduction 5 1. Prevalence 6 2. Diet, nutrition, physical activity and cancer survival 8 2.1 Nature of the evidence
More informationThe Neoadjuvant Model as a Translational Tool for Drug and Biomarker Development in Breast Cancer
The Neoadjuvant Model as a Translational Tool for Drug and Biomarker Development in Breast Cancer Laura Spring, MD Breast Medical Oncology Massachusetts General Hospital Primary Mentor: Dr. Aditya Bardia
More informationEndocrine Therapy in Premenopausal Breast Cancer. Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology, PA US Oncology
Endocrine Therapy in Premenopausal Breast Cancer Joyce O Shaughnessy, MD Baylor Sammons Cancer Center Texas Oncology, PA US Oncology Ovarian Ablation or Suppression vs. Not in ER + or ER UK Breast Cancer
More informationCan Diet Modulate Inflammation and Reduce Cancer Risk and Improve Survival? Evidence from the WHI
Can Diet Modulate Inflammation and Reduce Cancer Risk and Improve Survival? Evidence from the WHI Fred Tabung, MSPH, PhD Departments of Nutrition and Epidemiology Harvard T. H. Chan School of Public Health
More informationSupplementary Table 1. Association of rs with risk of obesity among participants in NHS and HPFS
Supplementary Table 1. Association of rs3826795 with risk of obesity among participants in NHS and HPFS Case/control NHS (1990) HPFS (1996) OR (95% CI) P- value Case/control OR (95% CI) P- value Obesity
More informationPadma Tadi-Uppala, Ph.D. Loma Linda University, School of Public Health, CA August 10, 2010
Padma Tadi-Uppala, Ph.D. Loma Linda University, School of Public Health, CA August 10, 2010 Provide information about lifestyle factors such as diet, exercise and stress management that can prevent breast
More informationExercise is Medicine for Cancer Management
18/8/211 for Cancer Management Presented by: Robert Newton, PhD, Perth, Australia the human genome evolved over at least the last 5, years within an environment of high physical activity the current human
More informationAdjuvant Systemic Therapy in Early Stage Breast Cancer
Adjuvant Systemic Therapy in Early Stage Breast Cancer Julie R. Gralow, M.D. Director, Breast Medical Oncology Jill Bennett Endowed Professor of Breast Cancer Professor, Global Health University of Washington
More informationInternational Graduate Course in Exercise & Clinical Physiology
International Graduate Course in Exercise & Clinical Physiology Exercise and Cancer A view to the future through the eyes of the past Robert D. Kilgour, Ph.D., FACSM Professor & Chair Department of Exercise
More informationHormone therapyduration: Can weselectthosepatientswho benefitfromtreatmentextension?
Hormone therapyduration: Can weselectthosepatientswho benefitfromtreatmentextension? Ivana Sestak, PhD Centre for Cancer Prevention Wolfson Institute of Preventive Medicine Queen Mary University London
More information